COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 17 for:    triplet | Huntington Disease

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD (SHIELD HD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04406636
Recruitment Status : Active, not recruiting
First Posted : May 28, 2020
Last Update Posted : November 19, 2020
Medpace, Inc.
Information provided by (Responsible Party):
Triplet Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : December 2022